Cargando…

Unique neoantigens expressed by melanomas and common epithelial cancers presented by multiple HLA alleles can be efficiently identified utilizing peptide prediction algorithms

Detalles Bibliográficos
Autores principales:	Trebska-Mcgowan, Kasia, Bharathan, Mini, Gartner, Jared J, Prickett, Todd D, Rosenberg, Steven A, Robbins, Paul F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645227/ http://dx.doi.org/10.1186/2051-1426-3-S2-P57

Ejemplares similares

Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
por: Crystal, Jessica S, et al.
Publicado: (2015)

Individual cultures of melanoma tumor infiltrating lymphocytes possess distinct patterns of reactivity with mutated antigens identified by whole exome sequencing of autologous tumors
por: Crystal, Jessica S, et al.
Publicado: (2014)

Tetramer based approach for efficient identification and isolation of neo-antigen specific CD8 T cells from peripheral blood (PBL) of patients with metastatic cancers
por: Bharathan, Mini, et al.
Publicado: (2015)

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer
por: Deniger, Drew C, et al.
Publicado: (2015)

Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing
por: Lu, Yong-Chen, et al.
Publicado: (2021)

High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity
por: Anna, Pasetto, et al.
Publicado: (2015)

Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens
por: Parikh, Anup Y., et al.
Publicado: (2023)

Discovery and characterization of an immunogenic neoantigen in a patient with metastatic triple negative breast cancer
por: Assadipour, Yasmine, et al.
Publicado: (2015)

Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma
por: Leko, Vid, et al.
Publicado: (2021)

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
por: Gros, Alena, et al.
Publicado: (2015)

Study and characterization of mutated antigen specific T cells isolated from fresh tumor and peripheral lymphocytes in cancer patients
por: Cohen, Cyrille, et al.
Publicado: (2015)

Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
por: Hanada, Ken-ichi, et al.
Publicado: (2015)

Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients
por: Park, Tristen S., et al.
Publicado: (2017)

Durable complete response in a patient with metastatic melanoma following adoptive transfer of autologous T cells recognizing 10 mutated tumor antigens
por: Prickett, Todd D, et al.
Publicado: (2015)

Use of endoloop in video-assisted thoracoscopic enucleation of a very rare esophageal tumor
por: Alwatari, Yahya, et al.
Publicado: (2019)

Neoantigen Targetability in Progressive Advanced Melanoma
por: van den Bulk, Jitske, et al.
Publicado: (2023)

Common HLA Alleles Associated with Health, but Not with Facial Attractiveness
por: Coetzee, Vinet, et al.
Publicado: (2007)

Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
por: Kim, Sanghyun P., et al.
Publicado: (2022)

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
por: Hwang, Michael S., et al.
Publicado: (2021)

Melanoma and Human Leukocyte Antigen (HLA): Immunogenicity of 69 HLA Class I Alleles With 11 Antigens Expressed in Melanoma Tumors
por: Georgopoulos, Apostolos P, et al.
Publicado: (2023)

HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model
por: Schrörs, Barbara, et al.
Publicado: (2017)

Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes
por: Castro, Andrea, et al.
Publicado: (2019)

Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors
por: Wang, Wenwen, et al.
Publicado: (2022)

Cell surface marker-based capture of neoantigen-reactive CD8(+) T-cell receptors from metastatic tumor digests
por: Chatani, Praveen D, et al.
Publicado: (2023)

Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival
por: Richard, Guilhem, et al.
Publicado: (2021)

Computing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical Characteristics
por: Dhall, Anjali, et al.
Publicado: (2020)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
por: Newey, Alice, et al.
Publicado: (2019)

Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation
por: Prickett, Todd D., et al.
Publicado: (2014)

Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations
por: Iiizumi, Susumu, et al.
Publicado: (2019)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
por: Aparicio, Belén, et al.
Publicado: (2022)

Association of HLA alleles with autism
por: Sayad, Arezou, et al.
Publicado: (2018)

Molecular analysis of HLA-DQB1 alleles in childhood common acute lymphoblastic leukaemia.
por: Dearden, S. P., et al.
Publicado: (1996)

A common allele of HLA mediates asymptomatic SARS-CoV-2 infection
por: Augusto, Danillo G., et al.
Publicado: (2022)

A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection
por: Augusto, Danillo G., et al.
Publicado: (2023)

Neoantigen-Reactive T Cells: The Driving Force behind Successful Melanoma Immunotherapy
por: Davis, Lindy, et al.
Publicado: (2021)

Specific recognition of an FGFR2 fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma
por: White, Bradley Sinclair, et al.
Publicado: (2023)

NeoFox: annotating neoantigen candidates with neoantigen features
por: Lang, Franziska, et al.
Publicado: (2021)

Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors
por: Pan, Jenny H, et al.
Publicado: (2015)

HLA-DRB1∗16:01 and HLA-DQB1∗05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma
por: Wang, Xu, et al.
Publicado: (2021)

PyHLA: tests for the association between HLA alleles and diseases
por: Fan, Yanhui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dm0al723gtr6vrn8947abs3jns